Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
Boffito
Marta
M
Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK. martalbb@hotmail.com
Rossati
Antonella
A
Reynolds
Helen E
HE
Hoggard
Patrick G
PG
Back
David J
DJ
Di Perri
Giovanni
G
D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D003521:Cyclopropanes; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007700:Kinetics; D008691:Methadone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D009294:Narcotics / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000209:etiology*; D013997:Time Factors
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D009294:Narcotics; D010078:Oxazines; C098320:efavirenz; D008691:Methadone